The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and beyond

Journal of Biomolecular Screening

Volumn 21, Issue 2, 2016, Pages 176-186

  Haslam, Carl ^a   Hellicar, John ^a   Dunn, Adrian ^a   Fuetterer, Arne ^b   Hardy, Neil ^a   Marshall, Peter ^a   Paape, Rainer ^b   Pemberton, Michelle ^a   Resemannand, Anja ^b   Leveridge, Melanie ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b BRUKER DALTONIK GMBH   (Germany)

Author keywords

high throughput screening; MALDI TOF; mass spectrometry; RapidFire

Indexed keywords

ACETYLCHOLINESTERASE; ENZYME; HISTONE DEMETHYLASE; PROTEIN JMJD2C; UNCLASSIFIED DRUG; PEPTIDE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ASSAY; HIGH THROUGHPUT SCREENING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; SCALE UP; VALIDATION STUDY; CHEMISTRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; PROCEDURES;

ACETYLCHOLINESTERASE; CHROMATOGRAPHY, LIQUID; HIGH-THROUGHPUT SCREENING ASSAYS; HISTONE DEMETHYLASES; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84954515691     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057115608605     Document Type: Article

References (30)

1. Valler M. J., Green D., Diversity Screening vs. Focused Screening in Drug Discovery. Drug Discov. Today 2000, 5 (7), 286-293.
2. Macarron R., Critical Review of the Role of HTS in Drug Discovery. Drug Discov. Today 2006, 11 (7/8), 277-279.
3. Mayr L. M., Fuerst P., The Future of High-Throughput Screening. J. Biomol. Screen. 2008, 13 (6), 443-448.
4. Ma H., Deacon S., Horiuchi K., The Challenge of Selecting Protein Kinase Assays for Lead Discovery Optimization. Expert Opin. Drug Discov. 2008, 3 (6), 607-621.
5. Wu X., Glickman J. F., Bowen B. R., et al. Comparison of Assay Technologies for a Nuclear Receptor Assay Screen Reveals Differences in the Sets of Identified Functional Antagonists. J. Biomol. Screen. 2003, 8, 381-392.
6. De-Rond T., Danielewicz M., Northern T., High Throughput Screening of Enzyme Activity with Mass Spectrometry Imaging. Curr. Opin. Biotechnol. 2015, 31, 1-9.
7. Leveridge M. V., Buxton R., Argyrides A., et al. Demonstrating Enhanced Throughput of RapidFire Mass Spectrometry through Multiplexing Using the JmjD2d Demethylase as a Model System. J. Biomol. Screen. 2014, 19 (2), 278-286.
8. Adam G. C., Meng J., Rizzo J. M., et al. Use of High-Throughput Mass Spectrometry to Reduce False Positives in Protease uHTS Screens. J. Biomol. Screen. 2015, 20 (2), 212-222.
9. Wu X., Wang J., Tan L., et al. In Vitro ADME Profiling Using High-Throughput RapidFire Mass Spectrometry: Cytochrome P450 Inhibition and Metabolic Stability Assays. J. Biomol. Screen. 2012, 17 (6), 761-772.
10. Hsieh F., Keshishian H., Muir C., Automated High Throughput Multiple Target Screening of Molecular Libraries by Microfluidic MALDI-TOF MS. J. Biomol. Screen. 1998, 3 (3), 189-198.
11. Gode D., Schmitt C., Engel M., et al. Screening Dyrk1A Inhibitors by MALDI-QqQ Mass Spectrometry: Systematic Comparison to Established Radiometric, Luminescence, and LC-UV-MS Assays. Anal. Bioanal. Chem. 2014, 406, 2841-2852.
12. Greis K. D., Zhou S., Burt T. M., et al. MALDI-TOF MS as a Label-Free Approach to Rapid Inhibitor Screening. J. Am. Soc. Mass Spectrom. 2006. 17 (6), 815-822.
13. Staab D., Busby S., Peltier J. M., et al. Implementation of a High-Throughput Screening Platform Using MALDI-MS as a Readout. Presented at the Society for Laboratory Automation and Screening Conference, Orlando, FL, June 12-16, 2013.
14. Dikler S., Busby S., Hill W. A. G., et al. High-Throughput Screening MALDI-TOF Assays Beyond 100,000 Samples per Day. Presented at the American Society for Mass Spectrometry Conference, St. Louis, MO, May 31-June 4, 2015.
15. Persike M., Zimmermann M., Klein J., et al. Quantitative Determination of Acetylcholine and Choline in Microdialysis Samples by MALDI-TOF MS. Anal. Chem. 2010, 82 (3), 922-929.
16. Sims R. J., Nishioka K., Reinberg D., Histone Lysine Methylation: A Signature for Chromatin Function. Trends Genet. 2003, 19 (11), 629-639.
17. Yang Z., Imoto I., Fukuda Y., et al. Identification of a Novel Gene, GASC1, within an Amplicon at 9p23-24 Frequently Detected in Esophageal Cancer Cell Lines. Can. Res. 2000, 60, 4735-4739.
18. Rathore R., Corr J. J., Lebre D. T., et al. Extending Matrix-Assisted Laser Desorption/Ionization Triple Quadrupole Mass Spectrometry Enzyme Screening Assays to Targets with Small Molecule Substrates. Rapid Commun. Mass Spectrom. 2009, 23, 3293-3300.
19. Sakurai M., Rose N. R., Schultz L., et al. A Miniaturized Screen for Inhibitors of Jumonji Histone Demethylases. Mol. Biosyst. 2010, 6, 357-364.
20. Hutchinson S. E., Leveridge M. V., Heathcote M. L., et al. Enabling Lead Discovery for Histone Lysine Demethylases by High-Throughput RapidFire Mass Spectrometry. J. Biomol. Screen. 2012, 17 (1), 39-48.
21. Rathore R., Pribil P., Corr J. J., et al. Multiplex Enzyme Assays and Inhibitor Screening by Mass Spectrometry. J. Biomol. Screen. 2010, 15 (8), 1001-1007.
22. Leveridge M., Bardera A. I., LaMarr W., et al. Lead Discovery for Microsomal Prostaglandin E Synthase Using a Combination of High-Throughput Fluorescent-Based Assays and RapidFire Mass Spectrometry. J. Biomol. Screen. 2012, 17 (5), 641-650.
23. Wigle T., Swinger K., Campbell J., et al. A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening. J. Biomol. Screen. 2015, 20 (6), 810-820.
24. Rose N. R., Woon E. C., Kingham G. L., et al. Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches. J. Med. Chem. 2010, 53 (4), 1810-1818.
25. King O. N., Li X. S., Sakurai M., et al. Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors. PLoS One 2010, 5 (11), e15535.
26. Heinrich M., Teoh H. L., Galanthamine from Snowdrop: The Development of a Modern Drug against Alzheimer's Disease from Local Caucasian Knowledge. J. Ethnopharmacol. 2004, 92, 147-162.
27. Luo W., Yu Q.-S., Kulkarni S. S., et al. Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (-) and (+): Tetrahydrofurobenzofuran and Methanobenzodioxepine. J. Med. Chem. 2006, 49 (7), 2174-2185.
28. Meetani M. A., Vorhees K. J., MALDI Mass Spectrometry Analysis of High Molecular Weight Proteins from Whole Bacterial Cells: Pretreatment of Samples with Surfactants. J. Am. Mass Spectrom. 2005, 16, 1422-1426.
29. Annis D. A., Nickbarg E., Yang X., et al. Affinity Selection-Mass Spectrometry Screening Technologies for Small Molecule Drug Discovery. Curr. Opin. Chem. Biol. 2007, 11, 518-256.
30. Patel K., Sherrill J., MrKsich M., et al. Discovery of SIRT3 Inhibitors Using SAMDI Mass Spectrometry. J. Biomol. Screen. 2015, 1087057115588512 [Epub ahead of print].